NCT02177981

Brief Summary

Coronary artery disease (CAD) is the leading cause of death worldwide. Patients with severe CAD are often treated with coronary artery bypass grafting (CABG). Novel treatment strategies need to be pursued to respond to the continuous increase in the risk profile of contemporary CABG patients. Surgical myocardial revascularization is commonly performed with the use of cardiopulmonary bypass (CPB). Neurological impairment following CABG may take on the form of a new-onset motor deficit or postoperative cognitive dysfunction. The former is rare, but potentially devastating. Conversely, declines in attention, memory and fine motor skills can frequently be documented. Ischemic preconditioning is a phenomenon of an endogenous protective response to organ ischemia, which is triggered by brief cycles of nonlethal ischemia and reperfusion in tissues known to be more resistant to ischemic insults. In clinical practice remote ischemic preconditioning (RIPC) is achieved by inflicting short periods of ischemia with intermittent restitution of flow to the upper extremity. This intervention has been shown to be effective in the reduction of myocardial injury in cardiac surgical patients. The hypothesis tested in this research proposal is that RIPC will decrease the extent of postoperative neurological injury following CABG. In this research project, 70 patients scheduled for an elective CABG will be recruited at a single center. They will be randomly allocated to either undergo RIPC (intervention arm) or a sham procedure (control arm). Inflating a blood pressure cuff to 200 mmHg for 5 min will induce RIPC, thereby inducing a brief period of ischemia. This will be followed by a 5-minute arm reperfusion. In total, three cycles of arm ischemia and reperfusion will be induced in this fashion. All patients will undergo pre- and post-procedural magnetic resonance imaging (MRI) of the brain, as well as neurocognitive testing. The array of MRI tools that will be used for the quantification of brain injury will include fluid attenuated inversion recovery, diffusion weighted and susceptibility weighted imaging, coupled with resting state functional MRI. The investigators aim to determine whether RIPC can reduce the adverse impact of CPB on neurological outcome as evaluated by MRI detectable brain ischemia and neurocognition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 30, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 25, 2018

Status Verified

April 1, 2018

Enrollment Period

1.6 years

First QC Date

April 7, 2014

Last Update Submit

April 23, 2018

Conditions

Keywords

Remote Ischemic PreconditioningCoronary Artery Bypass GraftingDiffusion Weighted Magnetic Resonance ImagingResting State Functional Magnetic Resonance ImagingPostoperative Cognitive Dysfunction

Outcome Measures

Primary Outcomes (1)

  • Composite structural and functional neurological outcome

    New ischemic lesions on brain MRI and postoperative neurocognitive dysfunction

    7 days

Secondary Outcomes (3)

  • Brain connectivity profiles

    7 days

  • Peri-operative brain injury

    7 days

  • Postoperative neurocognitive decline

    7 days

Study Arms (2)

Remote ischemic preconditioning

ACTIVE COMPARATOR

A blood pressure cuff will be placed on the left arm and three cycles of 5 min ischemia followed by 5 min reperfusion will be applied.

Procedure: Remote ischemic preconditioning

Control

SHAM COMPARATOR

The cuff will be placed around the arm but not inflated.

Procedure: Control

Interventions

A blood pressure cuff will be placed on the left arm and three cycles of 5 min ischemia followed by 5 min reperfusion will be applied.

Remote ischemic preconditioning
ControlPROCEDURE

The cuff will be placed around the arm but not inflated.

Control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with multi-vessel coronary artery disease undergoing primary, elective on-pump CABG
  • Written informed consent

You may not qualify if:

  • Prior stroke, transient ischemic attack or reversible ischemic neurologic deficit
  • Stenosis of the internal carotid artery (\>50%)
  • Significant peripheral arterial disease affecting the upper limbs
  • Acute coronary syndrome within 30 days prior to surgery
  • Inability to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Centre Zagreb

Zagreb, City of Zagreb, 10000, Croatia

Location

Related Publications (1)

  • Gasparovic H, Kopjar T, Rados M, Anticevic A, Rados M, Malojcic B, Ivancan V, Fabijanic T, Cikes M, Milicic D, Gasparovic V, Biocina B. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial. Trials. 2014 Oct 27;15:414. doi: 10.1186/1745-6215-15-414.

MeSH Terms

Conditions

Brain IschemiaPostoperative Cognitive Complications

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Hrvoje Gašparović, MD, PhD

    University of Zagreb School of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

April 7, 2014

First Posted

June 30, 2014

Study Start

March 1, 2014

Primary Completion

October 1, 2015

Study Completion

March 1, 2016

Last Updated

April 25, 2018

Record last verified: 2018-04

Locations